Protect Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-07-2024
- Paid Up Capital ₹ 0.50 M
as on 08-07-2024
- Company Age 26 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.75 M
as on 08-07-2024
- Revenue %
(FY 2022)
- Profit 25.52%
(FY 2022)
- Ebitda 34.78%
(FY 2022)
- Net Worth -2.48%
(FY 2022)
- Total Assets -0.55%
(FY 2022)
About Protect Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.75 M.
Yashoda Devadiga and Rajesh Devadiga serve as directors at the Company.
- CIN/LLPIN
U24239MH1998PTC114614
- Company No.
114614
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 1998
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Protect Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yashoda Devadiga  | Director | 23-Apr-1998 | Current |
| Rajesh Devadiga | Director | 23-Apr-1998 | Current |
Financial Performance of Protect Pharmaceuticals.
Protect Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 25.52% increase in profit. The company's net worth dipped by a decrease of 2.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Protect Pharmaceuticals?
In 2020, Protect Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 15 Jan 1999 | ₹0.75 M | Open |
How Many Employees Work at Protect Pharmaceuticals?
Unlock and access historical data on people associated with Protect Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Protect Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Protect Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
